1985
DOI: 10.1159/000233739
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Sarcoidosis: Pathogenesis, Staging and Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

1991
1991
2013
2013

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…Sarcoidosis is an inflammatory systemic disease characterized by noncaseating granulomas composed of epithelioid giant cells, macrophages, and lymphocytes5.…”
Section: Discussionmentioning
confidence: 99%
“…Sarcoidosis is an inflammatory systemic disease characterized by noncaseating granulomas composed of epithelioid giant cells, macrophages, and lymphocytes5.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with sarcoid, lymphocytes represent 50 to 60% of all cells recovered from a patient with active disease, and 95% are T lymphocytes. 60 Alveolar macrophages are also increased in patients with sarcoid.…”
Section: Disease Activitymentioning
confidence: 99%
“…Sarcoidosis (syn. M. Boeck, M. Besnier‐Boeck‐Schaumann) is an inflammatory systemic disease characterized by noncaseating granulomas composed of epitheloid giant cells, macrophages, and lymphocytes 1, 2. Although the etiology of sarcoidosis remains unclear, several studies suggest an interaction of genetic predisposition and triggering substances.…”
Section: Introductionmentioning
confidence: 99%